BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35171885)

  • 1. A Case of CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Secondary to Chronic Lymphedema.
    Sun L; Sun Y; Xin W; He J; Hu Y; Zhang H; Yu J; Zhang JA
    Am J Dermatopathol; 2022 Mar; 44(3):179-182. PubMed ID: 35171885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of primary cutaneous diffuse large B-cell lymphoma, leg type in a patient with chronic lymphedema of the leg.
    Vijaya B; Narahari SR; Shruthi MK; Aggithaaya G
    Indian J Pathol Microbiol; 2019; 62(3):470-472. PubMed ID: 31361244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema.
    Dargent JL; Lespagnard L; Feoli F; Debusscher L; Greuse M; Bron D
    Leuk Lymphoma; 2005 May; 46(5):775-80. PubMed ID: 16019518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors.
    Na HY; Choe JY; Shin SA; Kim HJ; Han JH; Kim HK; Oh SH; Kim JE
    PLoS One; 2019; 14(10):e0224247. PubMed ID: 31644584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous B-cell lymphoma of the leg in a chronic lymphedematous extremity.
    Torres-Paoli D; Sánchez JL
    Am J Dermatopathol; 2000 Jun; 22(3):257-60. PubMed ID: 10871070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 7. De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course.
    Ramachandran P; Sahni S; Wang JC
    J Investig Med High Impact Case Rep; 2019; 7():2324709619893546. PubMed ID: 31814435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5+ diffuse large B-cell lymphoma: a narrative review.
    Durani U; Ansell SM
    Leuk Lymphoma; 2021 Dec; 62(13):3078-3086. PubMed ID: 34284686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type.
    Lee WJ; Won KH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Suh C; Lee MW
    Acta Derm Venereol; 2016 Feb; 96(2):245-50. PubMed ID: 26014205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
    Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
    Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes.
    Lucioni M; Pescia C; Bonometti A; Fraticelli S; Moltrasio C; Ramponi A; Riboni R; Roccio S; Ferrario G; Arcaini L; Goteri G; Berti E; Paulli M
    Hum Pathol; 2021 May; 111():1-9. PubMed ID: 33548250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma.
    Niitsu N; Okamoto M; Tamaru JI; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Hirano M
    Ann Oncol; 2010 Oct; 21(10):2069-2074. PubMed ID: 20231297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Novo CD5-Positive Diffuse Large B-Cell Lymphoma: Report of a Case Presenting With Cutaneous Involvement and Featuring Extensive Intravascular Dissemination on Postmortem Examination.
    Úbeda Romero A; Santonja C; Blanco García A; Requena L; Rodríguez Pinilla SM
    Int J Surg Pathol; 2016 Dec; 24(8):763-768. PubMed ID: 27431754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
    Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
    G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
    Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
    Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma.
    Suzuki M; Muroi A; Nojima M; Numata A; Takasaki H; Sakai R; Yokose T; Miyagi Y; Koshikawa N
    Proteomics Clin Appl; 2020 Jan; 14(1):e1900091. PubMed ID: 31721454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases.
    Hembury TA; Lee B; Gascoyne RD; Macpherson N; Yang B; House N; Medeiros LJ; Hsi ED
    Am J Clin Pathol; 2002 Apr; 117(4):574-80. PubMed ID: 11939732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma.
    Suzuki Y; Sakakibara A; Shimada K; Shimada S; Ishikawa E; Nakamura S; Kato S; Takahara T; Asano N; Satou A; Kohno K
    Pathol Int; 2019 Jan; 69(1):13-20. PubMed ID: 30601579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic features and expression of OCT4 protein in testicular diffuse large B cell lymphoma].
    Chen YP; Zhu WF; Chen LF; Lu JP; He TM; Fu WD; Xu CW; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):383-387. PubMed ID: 28591984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.